Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Oct;49(10):4421-2.
doi: 10.1128/AAC.49.10.4421-4422.2005.

Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration

Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration

M D Edstein et al. Antimicrob Agents Chemother. 2005 Oct.
No abstract available

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Mean plasma atovaquone (ATQ) concentrations versus time after repeated atovaquone-proguanil treatment for uncomplicated Plasmodium falciparum malaria in three volunteers infected on three occasions. Plasma ATQ concentrations were measured by HPLC (•) and bioassay (○).

References

    1. Butcher, G. A., and R. E. Sinden. 2003. Persistence of atovaquone in human sera following treatment: inhibition of Plasmodium falciparum development in vivo and in vitro. Am. J. Trop. Med. Hyg. 68:111-114. - PubMed
    1. Edstein, M. D., S. Looareesuwan, C. Viravan, and D. E. Kyle. 1996. Pharmacokinetics of proguanil in malaria patients treated with proguanil plus atovaquone. Southeast Asian J. Trop. Med. Public Health 27:216-220. - PubMed
    1. Helsby, N. A., S. A. Ward, G. Edwards, R. E. Howells, and A. M. Breckenridge. 1990. The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism. Br. J. Clin. Pharmacol. 30:593-598. - PMC - PubMed
    1. Hussein, Z., J. Eaves, D. B. Hutchinson, and C. J. Canfield. 1996. Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone. Br. J. Clin. Pharmacol. 42:589-597. - PubMed
    1. Hussein, Z., J. Eaves, D. B. Hutchinson, and C. J. Canfield. 1997. Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum. Clin. Pharmacol. Ther. 61:518-530. - PubMed

MeSH terms

LinkOut - more resources